Opportunistic Infections Citation List:
March 2- March 15, 2012
ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. New Heterocyclic Compounds from 1,2,4-Triazole and 1,3,4-Thiadiazole Class Bearing Diphenylsulfone Moieties. Synthesis, Characterization and Antimicrobial Activity Evaluation.Barbuceanu, S.F., G. Saramet, G.L. Almajan, C. Draghici, F. Barbuceanu, and G. Bancescu. European Journal of Medicinal Chemistry, 2012. 49C: p. 417-423; PMID[22309915].
[PubMed]. OI_0302-031512.
2. Gliotoxin Effects on Fungal Growth: Mechanisms and Exploitation. Carberry, S., E. Molloy, S. Hammel, G. O'Keeffe, G.W. Jones, K. Kavanagh, and S. Doyle. Fungal Genetics and Biology : FG & B, 2012. [Epub ahead of print]; PMID[22405895].
[PubMed]. OI_0302-031512.
3. Antifungal Property of Dihydrodehydrodiconiferyl alcohol 9'-O-beta-D-Glucoside and Its Pore-forming Action in Plasma Membrane of Candida albicans. Choi, H., J. Cho, Q. Jin, E.R. Woo, and D.G. Lee. Biochimica et Biophysica Acta, 2012. [Epub ahead of print]; PMID[22406553].
[PubMed]. OI_0302-031512.
4. Biocompatibility and Antimicrobial Activity of Poly(3-Hydroxyoctanoate) Grafted with Vinylimidazole. Chung, M.G., H.W. Kim, B.R. Kim, Y.B. Kim, and Y.H. Rhee. International Journal of Biological Macromolecules, 2012. 50(2): p. 310-316; PMID[22210485].
[PubMed]. OI_0302-031512.
5. Synthesis and Antifungal Activity of a New Series of 2-(1H-Imidazol-1-yl)-1-Phenylethanol Derivatives.De Vita, D., L. Scipione, S. Tortorella, P. Mellini, B. Di Rienzo, G. Simonetti, F.D. D'Auria, S. Panella, R. Cirilli, R. Di Santo, and A.T. Palamara. European Journal of Medicinal Chemistry, 2012. 49C: p. 334-342; PMID[22321993].
[PubMed]. OI_0302-031512.
6. Antimicrobial Activity of Sesquiterpene Lactones Isolated from Traditional Medicinal Plant, Costus speciosus (Koen Ex.Retz.) Sm. Duraipandiyan, V., N.A. Al-Harbi, S. Ignacimuthu, and C. Muthukumar. Bmc Complementary and Alternative Medicine, 2012. 12(1): p. 13; PMID[22397713].
[PubMed]. OI_0302-031512.
7. Antimicrobial Activity of Ulopterol Isolated from Toddalia asiatica (L.) Lam.: A Traditional Medicinal Plant.Karunai Raj, M., C. Balachandran, V. Duraipandiyan, P. Agastian, and S. Ignacimuthu. Journal of Ethnopharmacology, 2012. 140(1): p. 161-165; PMID[22265751].
[PubMed]. OI_0302-031512.
8. Antibiofilm Activity of Certain Phytocompounds and Their Synergy with Fluconazole against Candida albicans Biofilms.Khan, M.S. and I. Ahmad. The Journal of Antimicrobial Chemotherapy, 2012. 67(3): p. 618-621; PMID[22167241].
[PubMed]. OI_0302-031512.
9. Four Butyrolactones and Diverse Bioactive Secondary Metabolites from Terrestrial Aspergillus flavipes Mm2: Isolation and Structure Determination. Nagia, M.M., M.M. El-Metwally, M. Shaaban, S.M. El-Zalabani, and A.G. Hanna. Organic and Medicinal Chemistry Letters, 2012. 2(1): p. 9; PMID[22380482].
[PubMed]. OI_0302-031512.
10. Fungal Biofilm Inhibitors from a Human Oral Microbiome-derived Bacterium. Wang, X., L. Du, J. You, J.B. King, and R.H. Cichewicz. Organic & Biomolecular Chemistry, 2012. 10(10): p. 2044-2050; PMID[22281750].
[PubMed]. OI_0302-031512.
11. Waikialoid A Suppresses Hyphal Morphogenesis and Inhibits Biofilm Development in Pathogenic Candida albicans.Wang, X., J. You, J.B. King, D.R. Powell, and R.H. Cichewicz. Journal of Natural Products, 2012. [Epub ahead of print]; PMID[22400916].
[PubMed]. OI_0302-031512.
12. In Vitro Interactions between Aspirin and Amphotericin B against Planktonic Cells and Biofilm Cells of C. albicans and C. parapsilosis. Zhou, Y., G. Wang, Y. Li, Y. Liu, Y. Song, W. Zheng, N. Zhang, X. Hu, S. Yan, and J. Jia. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22391539].
[PubMed]. OI_0302-031512.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
13. Novel Imidazo[2,1-B][1,3,4]thiadiazole Carrying Rhodanine-3-acetic acid as Potential Antitubercular Agents. Alegaon, S.G., K.R. Alagawadi, P.V. Sonkusare, S.M. Chaudhary, D.H. Dadwe, and A.S. Shah. Bioorganic & Medicinal Chemistry Letters, 2012. 22(5): p. 1917-1921; PMID[22325950].
[PubMed]. OI_0302-031512.
14. Evaluation of Small Molecule Tuberculostats for Targeting Tuberculosis Infections of the Central Nervous System.Bartzatt, R. Central Nervous System Agents in Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22409320].
[PubMed]. OI_0302-031512.
15. Preliminary Investigations of the Effect of Lipophilic Analogs of the Active Metabolite of Isoniazid Towards Bacterial and Plasmodial Strains. Delaine, T., V. Bernardes-Genisson, A. Quemard, P. Constant, F. Cosledan, B. Meunier, and J. Bernadou. Chemical Biology & Drug Design, 2012. [Epub ahead of print]; PMID[22405039].
[PubMed]. OI_0302-031512.
16. 1,4-Diarylpiperazines and Analogs as Anti-tubercular Agents: Synthesis and Biological Evaluation. Forge, D., D. Cappoen, J. Laurent, D. Stanicki, A. Mayence, T.L. Huang, L. Verschaeve, K. Huygen, and J.J. Vanden Eynde. European Journal of Medicinal Chemistry, 2012. 49C: p. 95-101; PMID[22301215].
[PubMed]. OI_0302-031512.
17. Trisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase Inhibitors. Gising, J., M.T. Nilsson, L.R. Odell, S. Yahiaoui, M. Lindh, H. Iyer, A.M. Sinha, B.R. Srinivasa, M. Larhed, S.L. Mowbray, and A. Karlen. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22369127].
[PubMed]. OI_0302-031512.
18. Novel Metal Based Anti-tuberculosis Agent: Synthesis, Characterization, Catalytic and Pharmacological Activities of Copper Complexes. Joseph, J., K. Nagashri, and G.B. Janaki. European Journal of Medicinal Chemistry, 2012. 49C: p. 151-163; PMID[22321994].
[PubMed]. OI_0302-031512.
19. Design, Synthesis of Some New (2-Aminothiazol-4-yl)methylester Derivatives as Possible Antimicrobial and Antitubercular Agents. Karuvalam, R.P., K.R. Haridas, S.K. Nayak, T.N. Guru Row, P. Rajeesh, R. Rishikesan, and N.S. Kumari. European Journal of Medicinal Chemistry, 2012. 49C: p. 172-182; PMID[22280817].
[PubMed]. OI_0302-031512.
20. Anti-Mycobacterial Diynes from the Canadian Medicinal Plant Aralia nudicaulis. Li, H., T. O'Neill, D. Webster, J.A. Johnson, and C.A. Gray. Journal of Ethnopharmacology, 2012. 140(1): p. 141-144; PMID[22234257].
[PubMed]. OI_0302-031512.
21. Synthesis and Evaluation of Anti-tubercular and Antibacterial Activities of New 4-(2,6-Dichlorobenzyloxy)phenyl Thiazole, Oxazole and Imidazole Derivatives. Part 2.Lu, X., X. Liu, B. Wan, S.G. Franzblau, L. Chen, C. Zhou, and Q. You. European journal of medicinal chemistry, 2012. 49C: p. 164-171; PMID[22264895].
[PubMed]. OI_0302-031512.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
22. In Vitro Antimalarial Activity and Molecular Docking Analysis of 4-Aminoquinoline Clubbed 1,3,5-Triazine Derivatives. Bhat, H.R., S.K. Ghosh, A. Prakash, K. Gogoi, and U.P. Singh. Letters in Applied Microbiology, 2012. [Epub ahead of print]; PMID[22394198].
[PubMed]. OI_0302-031512.
23. Biological Activities of Nitidine, a Potential Anti-malarial Lead Compound. Bouquet, J., M. Rivaud, S. Chevalley, E. Deharo, V. Jullian, and A. Valentin. Malaria Journal, 2012. 11(1): p. 67; PMID[22404785].
[PubMed]. OI_0302-031512.
24. Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug. da Cruz, F.P., C. Martin, K. Buchholz, M.J. Lafuente-Monasterio, T. Rodrigues, B. Sonnichsen, R. Moreira, F.J. Gamo, M. Marti, M.M. Mota, M. Hannus, and M. Prudencio. The Journal of Infectious Diseases, 2012. [Epub ahead of print]; PMID[22396598].
[PubMed]. OI_0302-031512.
25. Proveblue (Methylene Blue) as an Antimalarial Agent: In Vitro Synergy with Dihydroartemisinin and Atorvastatin.Dormoi, J., A. Pascual, S. Briolant, R. Amalvict, S. Charras, E. Baret, E. Huyghues des Etages, M. Feraud, and B. Pradines. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22391526].
[PubMed]. OI_0302-031512.
26. Defibrotide Interferes with Several Steps of the Coagulation-inflammation Cycle and Exhibits Therapeutic Potential to Treat Severe Malaria. Francischetti, I.M., C.J. Oliveira, G.R. Ostera, S.B. Yager, F. Debierre-Grockiego, V. Carregaro, G. Jaramillo-Gutierrez, J.C. Hume, L. Jiang, S.E. Moretz, C.K. Lin, J.M. Ribeiro, C.A. Long, B.K. Vickers, R.T. Schwarz, K.B. Seydel, M. Iacobelli, H.C. Ackerman, P. Srinivasan, R.B. Gomes, X. Wang, R.Q. Monteiro, M. Kotsyfakis, A. Sa-Nunes, and M. Waisberg. Arteriosclerosis, Thrombosis, and Vascular Biology, 2012. 32(3): p. 786-798; PMID[22116094].
[PubMed]. OI_0302-031512.
27. Antimalarial Evaluation and Docking Studies of Hybrid Phenylthiazolyl-1,3,5-triazine Derivatives: A Novel and Potential Antifolate Lead for Pf-DHFR-TS Inhibition. Gahtori, P., S.K. Ghosh, P. Parida, A. Prakash, K. Gogoi, H.R. Bhat, and U.P. Singh. Experimental Parasitology, 2012. 130(3): p. 292-299; PMID[22233734].
[PubMed]. OI_0302-031512.
28. Absolute Configuration and Total Synthesis of a Novel Antimalarial Lipopeptide by the De Novo Preparation of Chiral Nonproteinogenic Amino Acids. Ghosh, S.K., B. Somanadhan, K.S. Tan, M.S. Butler, and M.J. Lear. Organic Letters, 2012. [Epub ahead of print]; PMID[22390733].
[PubMed]. OI_0302-031512.
29. 1,2-Disubstituted ferrocenyl carbohydrate Chloroquine Conjugates as Potential Antimalarial Agents. Herrmann, C., P.F. Salas, B.O. Patrick, C. de Kock, P.J. Smith, M.J. Adam, and C. Orvig. Dalton Transactions (Cambridge, England : 2003), 2012. [Epub ahead of print]; PMID[22378031].
[PubMed]. OI_0302-031512.
30. Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (Pfndh2). Leung, S.C., P. Gibbons, R. Amewu, G.L. Nixon, C. Pidathala, W.D. Hong, B. Pacorel, N.G. Berry, R. Sharma, P.A. Stocks, A. Srivastava, A.E. Shone, S. Charoensutthivarakul, L. Taylor, O. Berger, A. Mbekeani, A. Hill, N.E. Fisher, A.J. Warman, G.A. Biagini, S.A. Ward, and P.M. O'Neill. Journal of Medicinal Chemistry, 2012. 55(5): p. 1844-1857; PMID[22364417].
[PubMed]. OI_0302-031512.
31. Novel Potent Metallocenes against Liver Stage Malaria. Matos, J., F.P. da Cruz, E. Cabrita, J. Gut, F. Nogueira, V.E. do Rosario, R. Moreira, P.J. Rosenthal, M. Prudencio, and P. Gomes. Antimicrobial Agents and Chemotherapy, 2012. 56(3): p. 1564-1570; PMID[22155838].
[PubMed]. OI_0302-031512.
32. Differences in Anti-Malarial Activity of 4-Aminoalcohol quinoline Enantiomers and Investigation of the Presumed Underlying Mechanism of Action. Mullie, C., A. Jonet, C. Degrouas, N. Taudon, and P. Sonnet. Malaria Journal, 2012. 11(1): p. 65; PMID[22401346].
[PubMed]. OI_0302-031512.
33. Lipophilic Analogs of Zoledronate and Risedronate Inhibit Plasmodium Geranylgeranyl Diphosphate Synthase (Ggpps) and Exhibit Potent Antimalarial Activity. No, J.H., F. de Macedo Dossin, Y. Zhang, Y.L. Liu, W. Zhu, X. Feng, J.A. Yoo, E. Lee, K. Wang, R. Hui, L.H. Freitas-Junior, and E. Oldfield. Proceedings of the National Academy of Sciences of the United States of America, 2012. [Epub ahead of print]; PMID[22392982].
[PubMed]. OI_0302-031512.
34. Design, Synthesis and in Vitro Activity of Novel 2'-O-Substituted 15-Membered Azalides. Pesic, D., K. Starcevic, A. Toplak, E. Herreros, M.J. Vidal, M. Almela, D. Jelic, S. Alihodzic, R. Spaventi, and M. Peric. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22380766].
[PubMed]. OI_0302-031512.
35. Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (Pfndh2). Pidathala, C., R. Amewu, B. Pacorel, G.L. Nixon, P. Gibbons, W.D. Hong, S.C. Leung, N.G. Berry, R. Sharma, P.A. Stocks, A. Srivastava, A.E. Shone, S. Charoensutthivarakul, L. Taylor, O. Berger, A. Mbekeani, A. Hill, N.E. Fisher, A.J. Warman, G.A. Biagini, S.A. Ward, and P.M. O'Neill. Journal of Medicinal Chemistry, 2012. 55(5): p. 1831-1843; PMID[22364416].
[PubMed]. OI_0302-031512.
36. Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High Throughput Screening Program against the Novel Malarial Target, Pfndh2 : Increasing Hit Rate via Virtual Screening Methods. Sharma, R., A.S. Lawrenson, N. Fisher, A. Warman, A.E. Shone, A. Hill, A. Mbekeani, C. Pidathala, R. Amewu, S. Leung, P. Gibbons, D.W. Hong, P. Stocks, G.L. Nixon, J. Chadwick, J. Shearer, I. Gowers, D. Cronk, S.P. Parel, P.M. O'Neill, S.A. Ward, G. Biagini, and N.G. Berry. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22380711].
[PubMed]. OI_0302-031512.
37. Novel Hybrid Molecules Based on 15-Membered Azalide as Potential Antimalarial Agents. Starcevic, K., D. Pesic, A. Toplak, G. Landek, S. Alihodzic, E. Herreros, S. Ferrer, R. Spaventi, and M. Peric. European Journal of Medicinal Chemistry, 2012. 49C: p. 365-378; PMID[22321992].
[PubMed]. OI_0302-031512.
38. Gibberellin Biosynthetic Inhibitors Make Human Malaria Parasite Plasmodium falciparum Cells Swell and Rupture to Death. Toyama, T., M. Tahara, K. Nagamune, K. Arimitsu, Y. Hamashima, N.M. Palacpac, H. Kawaide, T. Horii, and K. Tanabe. Plos One, 2012. 7(3): p. e32246; PMID[22412858].
[PubMed]. OI_0302-031512.
ANTILEISHMANIAL COMPOUNDS (Leishmania spp.)
39. Monoterpenic Aldehydes as Potential Anti-leishmania Agents: Activity of Cymbopogon citratus and citral on L. infantum, L. tropica and L. major. Machado, M., P. Pires, A.M. Dinis, M. Santos-Rosa, V. Alves, L. Salgueiro, C. Cavaleiro, and M.C. Sousa. Experimental Parasitology, 2012. 130(3): p. 223-231; PMID[22227102].
[PubMed]. OI_0302-031512.
40. In Vitro Antiprotozoal and Cytotoxic Activity of 33 Ethonopharmacologically Selected Medicinal Plants from DR Congo. Musuyu Muganza, D., B.I. Fruth, J. Nzunzu Lami, G.K. Mesia, O.K. Kambu, G.L. Tona, R. Cimanga Kanyanga, P. Cos, L. Maes, S. Apers, and L. Pieters. Journal of Ethnopharmacology, 2012. [Epub ahead of print]; PMID[22394563].
[PubMed]. OI_0302-031512.
41. The Effect of Verapamil on in Vitro Susceptibility of Promastigote and Amastigote Stages of Leishmania tropica to Meglumine Antimoniate. Shokri, A., I. Sharifi, A. Khamesipour, N. Nakhaee, M. Fasihi Harandi, J. Nosratabadi, M. Hakimi Parizi, and M. Barati. Parasitology Research, 2012. 110(3): p. 1113-7; PMID[21847598].
[PubMed]. OI_0302-031512.
42. Discovery of Inhibitors of Leishmania beta-1,2-Mannosyltransferases Using a Click-Chemistry-Derived Guanosine Monophosphate Library. Van der Peet, P., J.E. Ralton, M.J. McConville, and S.J. Williams. Plos One, 2012. 7(2): p. e32642; PMID[22393429].
[PubMed]. OI_0302-031512.
Citations from the ISI Web of Knowledge Listings for O.I.
43. In Vitro Antimicrobial and Antioxidant Activities of Bark Extracts of Bauhinia purpurea. Avinash, P., I.H. Attitalla, M. Ramgopal, S. Ch, and M. Balaji. African Journal of Biotechnology, 2011. 10(45): p. 9160-9164; [ISI:000299734600022].
[WOS]. OI_0217-030112.
44. Effects of the Essential Oil of Zataria multiflora Boiss, a Thyme-like Medicinal Plant from Iran on the Growth and Sporulation of Aspergillus niger Both in Vitro and on Lime Fruits.Abdollahi, M., H. Hamzehzarghani, and M.J. Saharkhiz. Journal of Food Safety, 2011. 31(3): p. 424-432; [ISI:000300220800017].
[WOS]. OI_0302-031512.
45. Aqueous Extracts from the Bulbs of Tulbaghia Violacea Are Antifungal against Aspergillus flavus. Belewa, V., H. Baijnath, and B.M. Somai. Journal of Food Safety, 2011. 31(2): p. 176-184; [ISI:000300219200005].
[WOS]. OI_0302-031512.
46. Synthesis and Evaluation of Malonate-based Inhibitors of Phosphosugar-metabolizing Enzymes: Class Ii Fructose-1,6-bis-Phosphate aldolases, Type I Phosphomannose Isomerase, and Phosphoglucose Isomerase. Desvergnes, S., S. Courtiol-Legourd, R. Daher, M. Dabrowski, L. Salmon, and M. Therisod. Bioorganic & Medicinal Chemistry, 2012. 20(4): p. 1511-1520; [ISI:000300391200017].
[WOS]. OI_0302-031512.
47. In Vivo Effect of Mint (Mentha viridis) Essential Oil on Growth and Aflatoxin Production by Aspergillus flavus Isolated from Stored Corn. Gibriel, Y.A.Y., A.S. Hamza, A.Y. Gibriel, and S.M. Mohsen. Journal of Food Safety, 2011. 31(4): p. 445-451; [ISI:000300221500003].
[WOS]. OI_0302-031512.
48. Scopoletin in Cassava Products as an Inhibitor of Aflatoxin Production. Gnonlonfin, G.J.B., Y. Adjovi, F. Gbaguidi, J. Gbenou, D. Katerere, L. Brimer, and A. Sanni. Journal of Food Safety, 2011. 31(4): p. 553-558; [ISI:000300221500017].
[WOS]. OI_0302-031512.
49. A Synthetic Peptide Derived from NK-lysin with Activity against Mycobacterium tuberculosis and Its Structure-function Relationship. Gu, H., R.J. Dai, K. Qiu, Z.Q. Teng, and H.Y. Wang. International Journal of Peptide Research and Therapeutics, 2011. 17(4): p. 301-306; [ISI:000300366900004].
[WOS]. OI_0302-031512.
50. Application of a Microcalorimetric Method for Determining Drug Susceptibility in Mycobacterium Species.Howell, M., D. Wirz, A.U. Daniels, and O. Braissant. Journal of Clinical Microbiology, 2012. 50(1): p. 16-20; [ISI:000299996600005].
[WOS]. OI_0302-031512.
51. New Oxadiazole Derivatives of Isonicotinohydrazide in the Search for Antimicrobial Agents: Synthesis and in Vitro Evaluation. Malhotra, M., M. Sanduja, A. Samad, and A. Deep. Journal of the Serbian Chemical Society, 2012. 77(1): p. 9-16; [ISI:000300386100002].
[WOS]. OI_0302-031512.
52. Rapid Throughput Analysis of Filamentous Fungal Growth Using Turbidimetric Measurements with the Bioscreen C: A Tool for Screening Antifungal Compounds. Medina, A., R.J.W. Lambert, and N. Magan. Fungal Biology, 2012. 116(1): p. 161-169; [ISI:000300114900015].
[WOS]. OI_0302-031512.
53. Sesquiterpene Aryl Ester Natural Products in North American Armillaria Species. Misiek, M. and D. Hoffmeister. Mycological Progress, 2012. 11(1): p. 7-15; [ISI:000300079600002].
[WOS]. OI_0302-031512.
54. Synthesis of 1,6-Hexanediyl-bis(semicarbazides) and 1,6-Hexanediyl-bis(1,2,4-triazol-5-ones) and Their Antiproliferative and Antimicrobial Activity. Pitucha, M., J. Rzymowska, A. Olender, and L. Grzybowska-Szatkowska. Journal of the Serbian Chemical Society, 2012. 77(1): p. 1-8; [ISI:000300386100001].
[WOS]. OI_0302-031512.
55. Antimicrobial Activity of Nanoemulsion on Cariogenic Planktonic and Biofilm Organisms. Ramalingam, K., B.T. Amaechi, R.H. Ralph, and V.A. Lee. Archives of Oral Biology, 2012. 57(1): p. 15-22; [ISI:000300122800003].
[WOS]. OI_0302-031512.
56. Capsicum Annuum L. trypsin Inhibitor as a Template Scaffold for New Drug Development against Pathogenic Yeast.Ribeiro, S.F.F., M.S. Silva, M. Da Cunha, A.O. Carvalho, G.B. Dias, G. Rabelo, E.O. Mello, C. Santa-Catarina, R. Rodrigues, and V.M. Gomes. Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology, 2012. 101(3): p. 657-670; [ISI:000300314200019].
[WOS]. OI_0302-031512.
57. Synthesis and Biological Activity of 4-Thiazolidinone Derivatives of Phenothiazine. Sharma, R., P. Samadhiya, S.D. Srivastava, and S.K. Srivastava. Journal of the Serbian Chemical Society, 2012. 77(1): p. 17-26; [ISI:000300386100003].
[WOS]. OI_0302-031512.
58. Composition and Antifungal Activity of the Brazilian Myristica fragrans Houtt Essential Oil. Valente, V.M.M., G.N. Jham, O.D. Dhingra, and I. Ghiviriga. Journal of Food Safety, 2011. 31(2): p. 197-202; [ISI:000300219200008].
[WOS]. OI_0302-031512.
59. Screening, Identification, and Characterization of Mechanistically Diverse Inhibitors of the Mycobacterium tuberculosis Enzyme, Pantothenate Kinase (Coaa). Venkatraman, J., J. Bhat, S.M. Solapure, J. Sandesh, D. Sarkar, S. Aishwarya, K. Mukherjee, S. Datta, K. Malolanarasimhan, B. Bandodkar, and K.S. Das. Journal of Biomolecular Screening, 2012. 17(3): p. 293-302; [ISI:000300192700002].
[WOS]. OI_0302-031512.
60. Screening Peptide Inhibitors Using Phage Peptide Library with Isocitrate Lyase in Mycobacterium tuberculosis as Target. Yin, Y.H., X. Niu, B. Sun, G.S. Teng, Y.H. Zhao, and C.M. Wu. Chemical Research in Chinese Universities, 2011. 27(4): p. 635-640; [ISI:000294379100024].
[WOS]. OI_0302-031512.